Tokyo Tape
Sign in
← Muromachi Chemicals

Annual report

4885.TEDINET S100UA72
Period2023-06-01 → 2024-05-31
Filed2024-08-28
StandardJapan GAAP
ConsolidatedNo
Data checks13 of 13 passed
Key figures · 95
MetricValuePeriodScopeSource row
Revenue¥6.4bn2023-06-01 → 2024-05-31StandaloneNet sales
Revenue¥6.3bn2022-06-01 → 2023-05-31StandaloneNet sales
Revenue¥5.7bn2021-06-01 → 2022-05-31dStandaloneNet sales (5-year summary)
Revenue¥4.9bn2020-06-01 → 2021-05-31dStandaloneNet sales (5-year summary)
Revenue¥5.3bn2019-06-01 → 2020-05-31dStandaloneNet sales (5-year summary)
Operating income¥422m2023-06-01 → 2024-05-31StandaloneOperating income
Operating income¥369m2022-06-01 → 2023-05-31StandaloneOperating income
Ordinary income¥428m2023-06-01 → 2024-05-31StandaloneOrdinary income
Ordinary income¥351m2022-06-01 → 2023-05-31StandaloneOrdinary income
Ordinary income¥423m2021-06-01 → 2022-05-31dStandaloneOrdinary income loss (5-year summary)
Ordinary income¥339m2020-06-01 → 2021-05-31dStandaloneOrdinary income loss (5-year summary)
Ordinary income¥272m2019-06-01 → 2020-05-31dStandaloneOrdinary income loss (5-year summary)
Ordinary income¥278m2019-06-01 → 2020-05-31dStandaloneOrdinary income loss (5-year summary)
Profit before tax¥469m2023-06-01 → 2024-05-31StandaloneIncome before income taxes
Profit before tax¥351m2022-06-01 → 2023-05-31StandaloneIncome before income taxes
Net income (owners)¥32m2019-06-01 → 2020-05-31dStandaloneProfit loss attributable to owners of parent (5-year summary)
Net income¥330m2023-06-01 → 2024-05-31StandaloneProfit loss
Net income¥256m2022-06-01 → 2023-05-31StandaloneProfit loss
Net income¥456m2021-06-01 → 2022-05-31dStandaloneNet income loss (5-year summary)
Net income¥181m2020-06-01 → 2021-05-31dStandaloneNet income loss (5-year summary)
Net income¥34m2019-06-01 → 2020-05-31dStandaloneNet income loss (5-year summary)
Total assets¥5.1bnat 2024-05-31StandaloneAssets
Total assets¥4.9bnat 2023-05-31StandaloneAssets
Total assets¥4.8bnat 2022-05-31dStandaloneTotal assets (5-year summary)
Total assets¥4.6bnat 2021-05-31dStandaloneTotal assets (5-year summary)
Total assets¥4.8bnat 2020-05-31dStandaloneTotal assets (5-year summary)
Total liabilities¥2.8bnat 2024-05-31StandaloneLiabilities
Total liabilities¥3.0bnat 2023-05-31StandaloneLiabilities
Net assets / equity¥2.3bnat 2024-05-31StandaloneNet assets
Net assets / equity¥1.9bnat 2023-05-31StandaloneNet assets
Net assets / equity¥1.7bnat 2022-05-31dStandaloneNet assets
Net assets / equity¥1.3bnat 2021-05-31dStandaloneNet assets (5-year summary)
Net assets / equity¥252mat 2020-05-31dStandaloneNet assets (5-year summary)
Cash and deposits¥1.1bnat 2024-05-31StandaloneCash and deposits
Cash and deposits¥853mat 2023-05-31StandaloneCash and deposits
Cash & equivalents¥1.1bnat 2024-05-31StandaloneCash and cash equivalents
Cash & equivalents¥853mat 2023-05-31StandaloneCash and cash equivalents
Cash & equivalents¥865mat 2022-05-31dStandaloneCash and cash equivalents
Cash & equivalents¥1.0bnat 2021-05-31dStandaloneCash and cash equivalents (5-year summary)
Cash & equivalents¥881mat 2020-05-31dStandaloneCash and cash equivalents (5-year summary)
Operating cash flow¥638m2023-06-01 → 2024-05-31StandaloneNet cash provided by used in operating activities
Operating cash flow¥317m2022-06-01 → 2023-05-31StandaloneNet cash provided by used in operating activities
Operating cash flow¥525m2021-06-01 → 2022-05-31dStandaloneNet cash provided by used in operating activities (5-year summary)
Operating cash flow¥488m2020-06-01 → 2021-05-31dStandaloneNet cash provided by used in operating activities (5-year summary)
Operating cash flow¥89m2019-06-01 → 2020-05-31dStandaloneNet cash provided by used in operating activities (5-year summary)
Investing cash flow−¥232m2023-06-01 → 2024-05-31StandaloneNet cash provided by used in investment activities
Investing cash flow−¥162m2022-06-01 → 2023-05-31StandaloneNet cash provided by used in investment activities
Investing cash flow−¥176m2021-06-01 → 2022-05-31dStandaloneNet cash provided by used in investing activities (5-year summary)
Investing cash flow−¥58m2020-06-01 → 2021-05-31dStandaloneNet cash provided by used in investing activities (5-year summary)
Investing cash flow¥137m2019-06-01 → 2020-05-31dStandaloneNet cash provided by used in investing activities (5-year summary)
Financing cash flow−¥210m2023-06-01 → 2024-05-31StandaloneNet cash provided by used in financing activities
Financing cash flow−¥172m2022-06-01 → 2023-05-31StandaloneNet cash provided by used in financing activities
Financing cash flow−¥484m2021-06-01 → 2022-05-31dStandaloneNet cash provided by used in financing activities (5-year summary)
Financing cash flow−¥311m2020-06-01 → 2021-05-31dStandaloneNet cash provided by used in financing activities (5-year summary)
Financing cash flow¥42m2019-06-01 → 2020-05-31dStandaloneNet cash provided by used in financing activities (5-year summary)
EPS (basic)¥83.422023-06-01 → 2024-05-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥67.942022-06-01 → 2023-05-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥123.792021-06-01 → 2022-05-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥65.242020-06-01 → 2021-05-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥15.752019-06-01 → 2020-05-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥17.162019-06-01 → 2020-05-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (diluted)¥81.862023-06-01 → 2024-05-31StandaloneDiluted earnings per share (5-year summary)
EPS (diluted)¥64.122022-06-01 → 2023-05-31StandaloneDiluted earnings per share (5-year summary)
EPS (diluted)¥112.562021-06-01 → 2022-05-31dStandaloneDiluted earnings per share (5-year summary)
EPS (diluted)¥56.972020-06-01 → 2021-05-31dStandaloneDiluted earnings per share (5-year summary)
Dividend per share¥222023-06-01 → 2024-05-31StandaloneDividend paid per share (5-year summary)
Dividend per share¥192022-06-01 → 2023-05-31StandaloneDividend paid per share (5-year summary)
Dividend per share¥192021-06-01 → 2022-05-31dStandaloneDividend paid per share (5-year summary)
Dividend per share¥152020-06-01 → 2021-05-31dStandaloneDividend paid per share (5-year summary)
Dividend per share¥32019-06-01 → 2020-05-31dStandaloneDividend paid per share (5-year summary)
Net assets per share¥571.26at 2024-05-31StandaloneNet assets per share (5-year summary)
Net assets per share¥487.25at 2023-05-31StandaloneNet assets per share (5-year summary)
Net assets per share¥450.37at 2022-05-31dStandaloneNet assets per share (5-year summary)
Net assets per share¥363.93at 2021-05-31dStandaloneNet assets per share (5-year summary)
Net assets per share¥101.92at 2020-05-31dStandaloneNet assets per share (5-year summary)
Equity ratio44.9%at 2024-05-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio38.7%at 2023-05-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio35.0%at 2022-05-31dStandaloneEquity to asset ratio (5-year summary)
Equity ratio28.9%at 2021-05-31dStandaloneEquity to asset ratio (5-year summary)
Equity ratio5.3%at 2020-05-31dStandaloneEquity to asset ratio (5-year summary)
ROE15.8%2023-06-01 → 2024-05-31StandaloneRate of return on equity (5-year summary)
ROE14.3%2022-06-01 → 2023-05-31StandaloneRate of return on equity (5-year summary)
ROE30.3%2021-06-01 → 2022-05-31dStandaloneRate of return on equity (5-year summary)
ROE22.8%2020-06-01 → 2021-05-31dStandaloneRate of return on equity (5-year summary)
ROE16.0%2019-06-01 → 2020-05-31dStandaloneRate of return on equity (5-year summary)
Shares issued4,095,500at 2024-05-31StandaloneTotal number of issued shares (5-year summary)
Shares issued4,095,500at 2023-05-31StandaloneTotal number of issued shares (5-year summary)
Shares issued4,095,500at 2022-05-31dStandaloneTotal number of issued shares (5-year summary)
Shares issued4,095,500at 2021-05-31dStandaloneTotal number of issued shares (5-year summary)
Shares issued775,000at 2020-05-31dStandaloneTotal number of issued shares (5-year summary)
Employees205at 2024-05-31StandaloneNumber of employees
Employees205at 2023-05-31StandaloneNumber of employees
Employees197at 2022-05-31dStandaloneNumber of employees
Employees195at 2021-05-31dStandaloneNumber of employees
Employees196at 2020-05-31dStandaloneNumber of employees

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 53
SegmentItemPeriodValue
Reconciling Itemsreconcilingsegment assetsat 2024-05-31¥1.6bn
Chemical Products Businessreportable segmentcapex2023-06-01 → 2024-05-31¥77m
Chemical Products Businessreportable segmentdepreciation2023-06-01 → 2024-05-31¥56m
Chemical Products Businessreportable segmentemployeesat 2024-05-3154 pure
Chemical Products Businessreportable segmentrevenue2023-06-01 → 2024-05-31¥2.3bn
Chemical Products Businessreportable segmentrevenue external2023-06-01 → 2024-05-31¥2.3bn
Chemical Products Businessreportable segmentsegment assetsat 2024-05-31¥1.1bn
Chemical Products Businessreportable segmentsegment profit2023-06-01 → 2024-05-31−¥16m
Healthy Food Businessreportable segmentcapex2023-06-01 → 2024-05-31¥15m
Healthy Food Businessreportable segmentdepreciation2023-06-01 → 2024-05-31¥27m
Healthy Food Businessreportable segmentemployeesat 2024-05-3119 pure
Healthy Food Businessreportable segmentrevenue2023-06-01 → 2024-05-31¥834m
Healthy Food Businessreportable segmentrevenue external2023-06-01 → 2024-05-31¥834m
Healthy Food Businessreportable segmentsegment assetsat 2024-05-31¥473m
Healthy Food Businessreportable segmentsegment profit2023-06-01 → 2024-05-31−¥38m
Pharmaceutical Businessreportable segmentcapex2023-06-01 → 2024-05-31¥198m
Pharmaceutical Businessreportable segmentdepreciation2023-06-01 → 2024-05-31¥54m
Pharmaceutical Businessreportable segmentemployeesat 2024-05-3153 pure
Pharmaceutical Businessreportable segmentrevenue2023-06-01 → 2024-05-31¥3.3bn
Pharmaceutical Businessreportable segmentrevenue external2023-06-01 → 2024-05-31¥3.3bn
Pharmaceutical Businessreportable segmentsegment assetsat 2024-05-31¥1.9bn
Pharmaceutical Businessreportable segmentsegment profit2023-06-01 → 2024-05-31¥476m
Total Of Reportable Segments And Otherssegment totalcapex2023-06-01 → 2024-05-31¥289m
Total Of Reportable Segments And Otherssegment totaldepreciation2023-06-01 → 2024-05-31¥136m
Total Of Reportable Segments And Otherssegment totalrevenue2023-06-01 → 2024-05-31¥6.4bn
Total Of Reportable Segments And Otherssegment totalrevenue external2023-06-01 → 2024-05-31¥6.4bn
Total Of Reportable Segments And Otherssegment totalsegment assetsat 2024-05-31¥3.5bn
Total Of Reportable Segments And Otherssegment totalsegment profit2023-06-01 → 2024-05-31¥422m
Reconciling Itemsreconcilingsegment assetsat 2023-05-31¥1.3bn
Chemical Products Businessreportable segmentcapex2022-06-01 → 2023-05-31¥37m
Chemical Products Businessreportable segmentdepreciation2022-06-01 → 2023-05-31¥50m
Chemical Products Businessreportable segmentrevenue2022-06-01 → 2023-05-31¥2.1bn
Chemical Products Businessreportable segmentrevenue external2022-06-01 → 2023-05-31¥2.1bn
Chemical Products Businessreportable segmentsegment assetsat 2023-05-31¥1.2bn
Chemical Products Businessreportable segmentsegment profit2022-06-01 → 2023-05-31−¥50m
Healthy Food Businessreportable segmentcapex2022-06-01 → 2023-05-31¥17m
Healthy Food Businessreportable segmentdepreciation2022-06-01 → 2023-05-31¥28m
Healthy Food Businessreportable segmentrevenue2022-06-01 → 2023-05-31¥658m
Healthy Food Businessreportable segmentrevenue external2022-06-01 → 2023-05-31¥658m
Healthy Food Businessreportable segmentsegment assetsat 2023-05-31¥395m
Healthy Food Businessreportable segmentsegment profit2022-06-01 → 2023-05-31−¥120m
Pharmaceutical Businessreportable segmentcapex2022-06-01 → 2023-05-31¥128m
Pharmaceutical Businessreportable segmentdepreciation2022-06-01 → 2023-05-31¥45m
Pharmaceutical Businessreportable segmentrevenue2022-06-01 → 2023-05-31¥3.5bn
Pharmaceutical Businessreportable segmentrevenue external2022-06-01 → 2023-05-31¥3.5bn
Pharmaceutical Businessreportable segmentsegment assetsat 2023-05-31¥2.0bn
Pharmaceutical Businessreportable segmentsegment profit2022-06-01 → 2023-05-31¥539m
Total Of Reportable Segments And Otherssegment totalcapex2022-06-01 → 2023-05-31¥181m
Total Of Reportable Segments And Otherssegment totaldepreciation2022-06-01 → 2023-05-31¥122m
Total Of Reportable Segments And Otherssegment totalrevenue2022-06-01 → 2023-05-31¥6.3bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-06-01 → 2023-05-31¥6.3bn
Total Of Reportable Segments And Otherssegment totalsegment assetsat 2023-05-31¥3.6bn
Total Of Reportable Segments And Otherssegment totalsegment profit2022-06-01 → 2023-05-31¥369m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 1,231
ItemContextValueUnit
Transactions with other segmentsCurrentYearDuration_NonConsolidatedMember_jpcrp030000-asr_E36350-000ChemicalProductsBusinessReportableSegmentMember－JPY
Transactions with other segmentsCurrentYearDuration_NonConsolidatedMember_TotalOfReportableSegmentsAndOthersMember－JPY
Transactions with other segmentsCurrentYearDuration_NonConsolidatedMember_ReconcilingItemsMember－JPY
Transactions with other segmentsCurrentYearDuration_NonConsolidatedMember－JPY
Net salesCurrentYearDuration_NonConsolidatedMember_jpcrp030000-asr_E36350-000PharmaceuticalBusinessReportableSegmentMember3258516000JPY
Net salesCurrentYearDuration_NonConsolidatedMember_jpcrp030000-asr_E36350-000HealthyFoodBusinessReportableSegmentMember834465000JPY
Net salesCurrentYearDuration_NonConsolidatedMember_jpcrp030000-asr_E36350-000ChemicalProductsBusinessReportableSegmentMember2276115000JPY
Net salesCurrentYearDuration_NonConsolidatedMember_TotalOfReportableSegmentsAndOthersMember6369097000JPY
Net salesCurrentYearDuration_NonConsolidatedMember_ReconcilingItemsMember－JPY
Net salesCurrentYearDuration_NonConsolidatedMember6369097000JPY
Operating incomeCurrentYearDuration_NonConsolidatedMember_jpcrp030000-asr_E36350-000PharmaceuticalBusinessReportableSegmentMember475903000JPY
Operating incomeCurrentYearDuration_NonConsolidatedMember_jpcrp030000-asr_E36350-000HealthyFoodBusinessReportableSegmentMember-37791000JPY
Operating incomeCurrentYearDuration_NonConsolidatedMember_jpcrp030000-asr_E36350-000ChemicalProductsBusinessReportableSegmentMember-16273000JPY
Operating incomeCurrentYearDuration_NonConsolidatedMember_TotalOfReportableSegmentsAndOthersMember421837000JPY
Operating incomeCurrentYearDuration_NonConsolidatedMember_ReconcilingItemsMember－JPY
Operating incomeCurrentYearDuration_NonConsolidatedMember421837000JPY
AssetsCurrentYearInstant_NonConsolidatedMember_jpcrp030000-asr_E36350-000PharmaceuticalBusinessReportableSegmentMember1908653000JPY
AssetsCurrentYearInstant_NonConsolidatedMember_jpcrp030000-asr_E36350-000HealthyFoodBusinessReportableSegmentMember472993000JPY
AssetsCurrentYearInstant_NonConsolidatedMember_jpcrp030000-asr_E36350-000ChemicalProductsBusinessReportableSegmentMember1090836000JPY
AssetsCurrentYearInstant_NonConsolidatedMember_TotalOfReportableSegmentsAndOthersMember3472483000JPY
AssetsCurrentYearInstant_NonConsolidatedMember_ReconcilingItemsMember1586784000JPY
AssetsCurrentYearInstant_NonConsolidatedMember5059267000JPY
Depreciation segment informationCurrentYearDuration_NonConsolidatedMember_jpcrp030000-asr_E36350-000PharmaceuticalBusinessReportableSegmentMember53653000JPY
Depreciation segment informationCurrentYearDuration_NonConsolidatedMember_jpcrp030000-asr_E36350-000HealthyFoodBusinessReportableSegmentMember26750000JPY
Depreciation segment informationCurrentYearDuration_NonConsolidatedMember_jpcrp030000-asr_E36350-000ChemicalProductsBusinessReportableSegmentMember55784000JPY
Depreciation segment informationCurrentYearDuration_NonConsolidatedMember_TotalOfReportableSegmentsAndOthersMember136187000JPY
Depreciation segment informationCurrentYearDuration_NonConsolidatedMember_ReconcilingItemsMember－JPY
Depreciation segment informationCurrentYearDuration_NonConsolidatedMember136187000JPY
Increase in property plant and equipment and intangible assetsCurrentYearDuration_NonConsolidatedMember_jpcrp030000-asr_E36350-000PharmaceuticalBusinessReportableSegmentMember197831000JPY
Increase in property plant and equipment and intangible assetsCurrentYearDuration_NonConsolidatedMember_jpcrp030000-asr_E36350-000HealthyFoodBusinessReportableSegmentMember14621000JPY
Increase in property plant and equipment and intangible assetsCurrentYearDuration_NonConsolidatedMember_jpcrp030000-asr_E36350-000ChemicalProductsBusinessReportableSegmentMember76845000JPY
Increase in property plant and equipment and intangible assetsCurrentYearDuration_NonConsolidatedMember_TotalOfReportableSegmentsAndOthersMember289298000JPY
Increase in property plant and equipment and intangible assetsCurrentYearDuration_NonConsolidatedMember_ReconcilingItemsMember－JPY
Increase in property plant and equipment and intangible assetsCurrentYearDuration_NonConsolidatedMember289298000JPY
Document title cover pageFilingDateInstant
Original text (Japanese)有価証券報告書
Clause of stipulation cover pageFilingDateInstant
Original text (Japanese)金融商品取引法第24条第1項
Place of filing cover pageFilingDateInstant
Original text (Japanese)福岡財務支局長
Filing date cover pageFilingDateInstant2024-08-28
Fiscal year cover pageFilingDateInstant
Original text (Japanese)第78期(自　2023年6月1日　至　2024年5月31日)
Company name cover pageFilingDateInstant
Original text (Japanese)室町ケミカル株式会社
Company name in english cover pageFilingDateInstantMUROMACHI CHEMICALS INC.
Title and name of representative cover pageFilingDateInstant
Original text (Japanese)代表取締役社長　　青木　淳一
Address of registered headquarter cover pageFilingDateInstant
Original text (Japanese)福岡県大牟田市新勝立町一丁目38番5
Telephone number address of registered headquarter cover pageFilingDateInstant0944-41-2131
Name of contact person address of registered headquarter cover pageFilingDateInstant
Original text (Japanese)取締役　　井内　聡
Nearest place of contact cover pageFilingDateInstant
Original text (Japanese)福岡県大牟田市新勝立町一丁目38番5
Telephone number nearest place of contact cover pageFilingDateInstant0944-41-2131
Name of contact person nearest place of contact cover pageFilingDateInstant
Original text (Japanese)取締役　　井内　聡
Place for public inspection cover page (text)FilingDateInstantText · Plus
Edinet codeFilingDateInstantE36350

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 13 of 13 passed
balance sheet identitynon_consolidated 2023-05-31pass
balance sheet identitynon_consolidated 2024-05-31pass
dei present pass
period resolution pass
statement vs summary · net assetsnon_consolidated 2022-05-31pass
statement vs summary · net assetsnon_consolidated 2023-05-31pass
statement vs summary · net assetsnon_consolidated 2024-05-31pass
statement vs summary · operating cash flownon_consolidated 2022-06-01/2023-05-31pass
statement vs summary · operating cash flownon_consolidated 2023-06-01/2024-05-31pass
statement vs summary · revenuenon_consolidated 2022-06-01/2023-05-31pass
statement vs summary · revenuenon_consolidated 2023-06-01/2024-05-31pass
statement vs summary · total assetsnon_consolidated 2023-05-31pass
statement vs summary · total assetsnon_consolidated 2024-05-31pass